Flexible MS Care: New form of Tysabri® now available on the PBS

The Federal Government has announced the listing of new form...
Rohan Greenland The May 50K

From our CEO

Without doubt, 2024 is going to be a busy and...

Researchers unravel the roots of MS risk genes in Europe

Researchers have studied ancient DNA from different time periods to...

Researchers discover link between copper and demyelination in model of MS

Researchers investigating copper levels in a laboratory model of MS...

Improving Family Planning Resources for MS Specialists: Addressing the Gaps in Support for Individuals with MS

In a new follow-up study, researchers sought to understand how...

Annemarie Watson: transforming adversity into hope

Annemarie's life was marked by adversity, from her childhood disrupted...

NHMRC invests over $12 million in groundbreaking medical research for MS

The National Health and Medical Research Council (NHMRC) has recently...

Top 10 MS Australia News Stories of 2023

As we take our first steps into 2024, let’s take...

International Progressive MS Alliance announces funding of over €4.6 million towards new treatments for progressive MS

The International Progressive MS Alliance is funding two major initiatives...

Lived experience experts and researchers come together in Perth for MS Australia’s biennial conference

Lived experience experts and researchers come together in Perth for...

TrialSmart: Empowering the MS Community for clinical trials

MS Australia is delighted to launch TrialSmart, a new educational...

Hope for Cognitive Improvements in Progressive MS: The CogEx Study

New clinical trial investigated individuals with progressive MS experiencing cognitive...
Rohan Greenland The May 50K

From our CEO

CEO Rohan Greenland reflects on the key milestones MS Australia...

Inspire the Legacy of Love: Make a Difference for Tomorrow

Ken's MS diagnosis arrived like an unwelcome guest but inspired...

Recommendation to include Shingrix® on the PBS for individuals with moderate to high infection risk

The Pharmaceutical Benefits Advisory Committee (PBAC) has announced its recommendations...

Update on phase III results for evobrutinib in relapsing multiple sclerosis

The latest findings from the EVOLUTION trials indicated that evobrutinib...

Scanning the Future: AI’s Vision for Precision Care in MS

AI-powered MRI analysis advances personalised MS care in new study.

PLATYPUS: A new clinical trial for progressive MS

MS Australia, together with MSWA, is thrilled to announce that...

Newsletter subscription

  • Enter your details

Flexible MS Care: New form of Tysabri® now available on the PBS